MSX Opens Redemption for Pre-IPO Phase II Projects, Polymarket Delivers 33.3% Return

iconPANews
Share
This is the logo of the coin.
USDT
----
AI summary iconSummary
MSX has opened redemption for Phase II pre-IPO projects Anthropic and Polymarket, with Polymarket shares rising to $202.67 from $152, delivering a 33.3% return. Anthropic’s valuation also exceeds its subscription price. Investors can now redeem in USDT or hold until IPO. Altcoins to watch remain under focus as market sentiment shifts. The Fear & Greed Index shows mixed signals, but strong performance in pre-IPO tokens continues to draw attention. MSX previously completed Phase I with $CBRS.M and $SPCX.M.

PANews, August 20: According to an official announcement from MSX, the platform has officially opened redemption applications for the second phase of its Pre-IPO projects, Anthropic and Polymarket. Official data shows that, as of the latest valuation, Polymarket’s subscription price has risen from $152 per share to $202.67 per share, representing a paper profit of 33.3%; Anthropic’s latest valuation also exceeds its subscription price. Following this redemption opening, users may choose, based on their own needs, to redeem their holdings at the current market price and settle in USDT, or continue holding until the underlying assets complete their IPO. Previously, MSX successfully completed the full transaction cycle for the first phase of its Pre-IPO projects, $CBRS.M and $SPCX.M, from subscription to listing.

Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.